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Abstract
Like the major vaccinia virus (VV) core protein precursors, p4b and p25K, the 25 kDa VV A12L
late gene product (p17K) is proteolytically maturated at the conserved Ala-Gly-Ala motif.
However, the association of the precursor and its cleavage product with the core of mature virion
suggests that both of the A12L proteins may be required for virus assembly. Here, in order to test
the requirement of the A12L protein and its proteolysis in viral replication, a conditional lethal
mutant virus (vvtetOA12L) was constructed to regulate A12L expression by the presence or
absence of an inducer, tetracycline. In the absence of tetracycline, replication of vvtetOA12L was
inhibited by 80% and this inhibition could be overcome by transient expression of the wild-type
copy of the A12L gene. In contrast, mutation of the AG/A site abrogated the ability of the
transfected A12L gene to rescue, indicating that A12L proteolysis plays an important role in viral
replication. Electron microscopy analysis of the A12L deficient virus demonstrated the aberrant
virus particles, which were displayed by the AG/A site mutation. Thus, we concluded that the not
only A12L protein but also its cleavage processing plays an essential role in virus morphogenic
transition.
Background
Proteolytic processing in vaccinia virus (VV) plays an
important role in morphogenic transitions during the
virus replication cycle. To date, six VV-encoded, proteolyt-
ically processed proteins have been reported. They are the
gene products of A10L (p4a), A3L (p4b), L4R (p25K),
A17L (p21K), G7L, and A12L (p17K) [1-6]. Extensive
studies of these proteins have provided more specific
mechanisms of VV proteolysis in terms of the transforma-
tion of immature virions (IV) into intracellular mature vir-
ions (IMV).
One of the VV major core proteins, A10L has been shown
to be essential in virus replication and its absence in virus
assembly resulted in defective virus morphology such as
IV-like particles, which lacked granular viral materials and
consequently produced the irregular-shaped virus parti-
cles [7]. These morphogenic defects suggested that A10L
protein is required for the correct organization of the
nucleocomplex within the IVs [7,8]. L4R, a DNA binding
protein, plays an essential role in virus replication, being
involved in an early stage of infection such as early tran-
scription or unpackaging viral core and DNA [9,10]. The
L4R-deficient virus produced virus particles with non-
associated viroplasm and its surrounding viral mem-
branes, suggesting its role in correct incorporation of viral
DNA and cores with immature virus membrane.
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On the other hand, both the G7L and A17L gene products,
VV membrane proteins, are required for virus replication
and are involved in the early development of IV mem-
branes. G7L, a phosphoprotein in association with the
A30L and H5R proteins, is responsible for the correct
recruitment and attachment of crescent-shaped mem-
branes to viroplasms [11]. The absence of G7L caused
defective IV formation, which showed tubular elements
apart from the granular virus materials as well as empty
inside and multiple wrapped IV particles [5,12]. The A17L
mutant virus under non-permissive conditions produced
large aggregates of accumulated electron-dense materials
and numerous vesicles/tubules engulfing viroplasms,
demonstrating that A17L is an essential component for
generation of IV and IMV membranes [13,14,5]. A17L
(p21K) and its cleavage product (21K) co-localized with
GTPase Rab1, a marker of intermediate compartment (IC)
membranes, the origin of viral membrane [15] and dem-
onstrated the A17L participation in very early stage of the
membrane biogenesis. Thus, the researches on most of the
VV structural precursor proteins that undergo proteolytic
maturation elucidated that VV recruits and organizes the
first recognized membrane and induces the correct forma-
tion of viral genome content through the proteolysis of
viral core/membrane proteins. However, the essentiality
and biological role of the A12L gene products still
remained to be analyzed.
VV A12L is a late gene product, which is proteolytically
processed from a 25kDa precursor (p17K) into a 17kDa
cleavage product (17K) [4]. Its proteolysis is similar to the
processing of the other VV core proteins in that the cleav-
age is sensitive to rifampicin, takes place at the conserved
recognition motif, Ala-Gly-Ala (AG/A), and is associated
with mature virions. On the other hand, unlike other core
proteins, of which only the mature processed forms are
localized to the virion, the fact that both p17K and 17K
are observed in the core of mature virions suggests differ-
ent regulation and participation of A12L proteolysis in
virus assembly. In order to investigate the requirement of
the A12L protein and elucidate its role in virion-morpho-
genesis, we constructed a conditional lethal mutant virus
of A12L, of which protein expression can be regulated by
tetracycline (Tet) [16]. The mutant virus was designed to
have Tet operator in front of A12L open reading frame
(ORF), where Tet repressors constitutively expressed from
the T-REx 293 cell line bind to and block further transcrip-
tion of A12L. The addition of Tet, however, prevents Tet
repressors from binding to the Tet operator and switches
on A12L expression. Here, we report that the absence of
A12L results in approximately one log reduction of virus
replication in concert with phenotypic defects. In addi-
tion, plasmid borne A12L with an N-terminal AG/A site
mutation, which prevents A12L proteolysis, failed to res-
cue the A12L deficiency, demonstrating that A12L cleav-
age is essential for virus replication as well as formation of
mature virions.
Results
Tet-regulated conditional mutant virus of A12L
To examine the regulation of a conditional mutant virus
of A12L (vvtetOA12L), we infected T-REx 293 cells with
vvtetOA12L at various concentrations of Tet from 0 to 40
µg/mL (Fig. 1a). Virus yield increased as the concentration
of Tet increased from 0 to 30 µg/mL. This increased virus
yield demonstrates that vvtetOA12L replicates in a Tet-
dependent manner. Setting the optimal concentration of
Tet at 30 µg/mL, we performed a one-step growth curve of
vvtetOA12L with the cell extracts harvested at different
time points after infection (Fig. 1b). The one-step growth
curve shows the initial drop of virus yield at 5 hours post
infection (hpi), when the A12L protein begins to be
expressed as a late gene product. The maximum viral
yields of vvtetOA12L in the presence of Tet was obtained
at 24 hpi with approximately one log difference, which is
attributed to the expression of the A12L protein and its
essentiality in virus replication.
Essentiality of A12L protein and AG/A cleavage in VV 
replication
The sequence alignment of the A12L open reading frame
with other representative orthopoxviruses such as cow-
pox, variola, and ectromelia viruses has shown highly
conserved sequence alignment with more than 95 % iden-
tity (data not shown). Thus, it is expected that A12L may
be essential for virus replication. An A12L conditional
mutant virus (vvtetOA12L) was used to address the
requirement of the A12L protein and the AG/A site cleav-
age for viral replication. To begin with, A12L protein
expression was confirmed by immunoblot analysis with
A12L specific bands obtained only in the presence of Tet
(data not shown). Approximately 80 % reduction of virus
titer was observed in the absence of Tet (Fig 2), suggesting
that A12L plays an important role in viral replication.
Confirmation that the defect in replication was due to the
shut-off of A12L expression was obtained by a marker res-
cue experiment. Plasmid-borne A12L under the control of
either its native promoter, which includes 233 nucleotides
upstream of the A12L ORF (p233-A12L), or an early/late
synthetic promoter in pRB21 vector (pA12L) provided
almost 100% rescue in virus yield. This rescue experiment
established the requirement of A12L expression in viral
replication despite the leakiness of vvtetOA12L observed
with the 80% viral reduction. Another rescue experiment
of A12L expression with the AG/A site mutation (AG/A)
into ID/I, however, failed to complement the absence of
A12L protein, resulting in the similar virus yield to the
titer of vvtetOA12L infection in the absence of Tet. There-
fore, it is suggested that cleavage at the AG/A site plays an
essential role in A12L functionality.Virology Journal 2007, 4:73 http://www.virologyj.com/content/4/1/73
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Morphology defects in the absence of A12L expression
In order to study the phenotypic effects of A12L repres-
sion in virus assembly, T-REx 293 cells were infected with
vvtetOA12L in the presence and absence of Tet (Fig. 3). In
the presence of Tet, vvtetOA12L was able to assemble into
mature virions as wild type VV does, producing oval par-
ticles with condensed cores (Fig. 3a–b). In the absence of
Tet, vvtetOA12L displayed several phenotypic defects (Fig.
3c–d). The A12L deficiency caused accumulated granules
of electron-dense areas including viral DNA and protein-
rich aggregates (Fig. 3c) while crescent membranes were
formed. Some immature virus particles (IV) were devoid
of the internal materials or contained small IV contents
surrounded by irregular-shaped membranes (IV-like par-
ticles, IV*). This indicates that the absence of A12L might
delay or interrupt the viral membrane to adhere to the
viral materials, which eventually led to the abrogated for-
mation of spherical membranes. A small portion of the
abnormal IV particles was able to mature into IMV but the
core failed to form the characteristic of the bi-concave
shape. Rather, the cores of the IMV retained a round
shape, which appeared to lose the center-compressed con-
cave structure. Thus, we concluded that the A12L defi-
ciency led to not only the defects in the association of the
viral contents with crescent-shaped membranes but also
Essentiality of A12L protein in VV replication Figure 2
Essentiality of A12L protein in VV replication. In order 
to determine the essentiality of A12L protein in virus replica-
tion, T-REx 293 cells were infected with vvtetOA12L in the 
presence/absence of Tet (Tet+/-). The lack of A12L was 
complemented by the transient expression of plasmid born 
A12L under the control of an early/late synthetic promoter 
(pA12L) or the native promoter (233 nucleotide upstream of 
A12L ORF, p233-A12L). In addition, the N-terminal AG/A 
site mutated A12L was constructed to rescue the absence of 
A12L (AG/A). pA12L: A12L ORF under the control of the 
early/late synthetic promoter; p233-A12L: plasmid born 
A12L under the native promoter; pRB21: vector plasmid 
alone; AG/A: plasmid born A12L with N-terminal AG/A site 
mutation into ID/I. Each virus titer (PFU/ml) was scaled in log 
phase.
Tet-dependent replication of vvtetOA12L and one-step  growth curve Figure 1
Tet-dependent replication of vvtetOA12L and one-
step growth curve. a. Tet-dependent replication of 
vvtetOA12L. T-REx 293 cells were infected with vvtetOA12L 
at an MOI of 1 PFU/cell in the presence of tetracycline (Tet) 
at various concentrations of 0, 10, 20, 30, and 40 µg/mL. The 
infected cell extracts harvested at 24 hpi were titered on 
BSC 40 cells to determine the virus yields. b. One-step 
growth curve. T-REx 293 cells were infected with 
vvtetOA12L in the presence and absence of Tet (30 µg/mL) 
and harvested at 3, 5, 8, 12, and 24 hpi. Each virus titer (PFU/
ml) was scaled in log phase.Virology Journal 2007, 4:73 http://www.virologyj.com/content/4/1/73
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the formation of spherical IV membranes and subsequent
disruption of interior cores of the IMV.
Morphology defects by abrogated AG/A cleavage of A12L
The morphogenic defects of the mutant virus under the
restrictive conditions could be overcome by the transient
expression of plasmid borne A12L (Fig 4a). Consistent
with the rescue experiment, plasmid borne A12L (pA12L)
was able to form regular IV particles, which had electron-
dense viral materials inside and associated with the spher-
ical membrane tightly. In addition, a condensed core was
observed together with the development of the inner
layer, which established the biconcave characteristics of
IMV particles. The AG/A site mutated A12L, however,
failed to produce fully matured IMV particles (Fig. 4b–d).
Instead, the transient expression of AG/A site mutant
A12L demonstrated similar phenotypic deformities as the
absence of A12L, producing the irregular shaped IV-like
particles with little viral material. Similarly, IMV particles
retained round boundary membranes and abnormal
inner layers (Fig. 4d). This can be explained by the fact
that the impaired cleavage at an N-terminal AG/A site
might lead to the improper core condensation and a con-
cave inner core layer.
Discussion
Here, we were able to report that the A12L deficiency is
enough to delay viral replication as well as arrest the viral
morphogenic transitions. Marker rescue experiments with
pA12L and AG/A site mutated A12L (AG/A) not only con-
firmed the requirement of A12L in virus replication but
also demonstrated that the disrupted A12L proteolysis
eliminated its complementing functionality. This is also
supported by the electron microscope analysis, which
demonstrated the impaired morphological development
of IV toward IMV by the failure of AG/A cleavage event.
The phenotypic defects such as detached viral membrane
from the electron-dense virus materials, aberrant shape of
IV particles, and disrupted bi-concave core layer of IMV
particles suggest that A12L protein and its cleavage events
may participate in the viral morphogenesis throughout
from the early stage of IV formation to the very last stage
of fully matured IMV. The abnormal IV-like particles sim-
ilarly observed by the A10L deficiency imply that A12L
may have a role in correct formation of nucleoprotein
complex within the IV [7]. In addition, the abrogated
biconcave IMV particles extend its role in the formation of
a center-compressed core in IMV particles. In terms of the
generation of viral membranes, A12L deficient virus intro-
duced neither the absence of viral membrane nor unfin-
ished or interrupted IV membranes, which were observed
by the lack of A17L and A14L, respectively [17,18]. Thus,
A12L protein is speculated not to be responsible for the
generation of the crescent membranes but for their correct
positioning and linkage to viroplasm. The similar pheno-
typic arrests obtained by the blocked AG/A site cleavage to
the A12L deficient mutant virus may highlight the partic-
ipation of VV proteolysis in the correct assembly of nucle-
oprotein complex in IV particles, the capability to
maintain the stable spherical shape of IV, proper conden-
sation of the core and its layer into center-concaved IMV
formation. Therefore, additional characterization of the
vvtetOA12L mutant virus will lead to the more specific
biological function of the A12L protein during VV mor-
phogenic transitions and regulation of A12L proteolysis.
Conclusion
By demonstrating that A12L protein and its cleavage at an
N-terminal AG/A play an important role in viral replica-
tion, we were able to conclude that all the VV core precur-
sor proteins, which are proteolytically maturated, are
required for the production of infectious progeny. The
similar morphological defects observed by the A12L defi-
ciency and single site mutation (AG/A) of A12L give
Morphology defects in the absence of A12L expression Figure 3
Morphology defects in the absence of A12L expres-
sion. To investigate a role of A12L protein in virus assembly, 
T-REx 293 cells were infected by vvtetOA12L in the presence 
(a, b) and the absence of Tet (c, d). In the presence of Tet, 
spherical IV particles were demonstrated, which evolved into 
the biconcave IMV particles. The inner layer of the core is 
localized along with the outer membrane (panel b). In the 
absence of Tet (c and d), mostly IV-like particles (IV*) were 
observed with accumulated viroplasms (V). IV-like particles 
contained little of viral dense materials in the membranes, 
which formed irregular-shape. Some of IV particles were 
developed into IMV-like particles, of which cores showed 
abrogated condensation along with abnormal-shaped layer as 
demonstrated in box at the panel d.Virology Journal 2007, 4:73 http://www.virologyj.com/content/4/1/73
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emphasis to the significant participation of VV proteolysis
in the viral morphogenic transition.
Methods
Cell cultures
Monolayer of BSC-40 cells was maintained in Eagle's min-
imal essential medium (EMEM, Invitrogen) supple-
mented with 10% fetal calf serum (FCS, Invitrogen), 2
mM glutamine (Invitrogen), and 10 mM gentamicin sul-
fate (Invitrogen) at 37°C in a 95% humidified atmos-
phere containing 5% CO2. For infection of the
conditional mutant virus of A12L (vvtetOA12L), T-REx
293 cells (Invitrogen) were grown in Dulbecco's modified
Eagle's medium (D-MEM, Invitrogen) supplemented with
10% Tet system approved fetal bovine serum (BD Bio-
sciences), 2 mM Glutamax (Invitrogen), and 1% penicil-
lin-streptomycin (Invitrogen), and incubated as described
above. Blasticidin (5 µg/ml, Invitrogen) was added to the
D-MEM growth media for selection of the pcDNA6/TR
plasmid [19], which expresses the tetracycline repressors.
Construction of conditional mutant virus of A12L 
(vvtetOA12L)
VV WR was used for the construction of the conditional
mutant A12L virus (vvtetOA12L). The tetracycline opera-
tor (TetO) was inserted in front of the A12L ORF by virtue
of two-step polymerase chain reaction (PCR) and ampli-
fied with 215 nucleotides (nts) upstream of the A12L ORF
and 213 nts downstream of the A13L ORF. The PCR prod-
ucts were cloned into the p7.5:NEO vector [20], resulting
in the construction of the p7.5:TetOA12L:NEO plasmid.
Transfection of the p7.5:TetOA12L:NEO plasmid in con-
cert with VV WR infection induced the first recombina-
tion. The Neomycin resistance gene (NEOR) in the
p7.5:TetOA12L:NEO plasmid was used as a transient
selective marker in the presence of Geneticin G418 sulfate
(Invitrogen). The second recombination of NEOR-con-
taining viruses occurred in the absence of Geneticin G418
sulfate, producing a wild type virus and an A12L mutant
virus (vvtetOA12L) containing TetO without NEOR.
Plaque purifications were performed in concert with PCR
screens using the primers specific for TetO and 3' end of
A12L ORF to identify pure vvtetOA12L isolates. Experi-
mental infections of vvtetOA12L were carried out in T-REx
293 cell line to control the gene expression, which consti-
tutively provides the Tetracycline repressor.
Virus infections and titers
When T-REx 293 cells were approximately 80% confluent,
vvtetOA12L virus in phosphate-buffered saline (PBS) at an
MOI of 1 plaque forming unit (PFU)/cell were placed on
the cells for 30 min at room temperature. The infection D-
MEM containing 5% of Tet-approved FBS, L-glutamax (10
mM), penicillin-streptomycin (10 mM) was then added.
Tetracycline (10–30 µg/ml, Sigma-Aldrich) was placed in
infection D-MEM media for induction of the A12L pro-
tein. Cell extracts were harvested at 24–48 hours post
infection (hpi) by centrifugation (750 × g) for 5 min at
4°C, followed by three cycles of freezing and thawing to
lyse the cells. Virus titers were conducted on BSC-40 cells,
incubated at 37°C for 40 hours, and stained with 0.1%
crystal violet solution in 30% ethanol.
Transfection and marker rescue
In order to rescue the absence of A12L by plasmid-bourn
A12L (pA12L), full-length of A12L ORF was placed right
after an early/late synthetic promoter in pRB21 [21]. The
same ORF were placed in TOPO TA cloning vector (Invit-
Morphology defects by abrogated AG/A cleavage of A12L Figure 4
Morphology defects by abrogated AG/A cleavage of 
A12L. In order to examine VV morphology by rescuing the 
absence of A12L, we transfected plasmid born A12L under 
the control of an early/late synthetic promoter (pA12L) and 
AG/A mutant plasmid of A12L (AG/A), and infected with 
vvtetOA12L in the absence of Tet. The transient expression 
of A12L induced regular IV and IMV particles (panel a) while 
the AG/A mutation into ID/I displayed defective phenotypes 
(panel b through d). Arrows in panel a indicate center-con-
caved inner layer of the core. Panel b and c show IV particles 
with little or almost empty viral materials while panel d dem-
onstrates the aberrant layers of the cores.Virology Journal 2007, 4:73 http://www.virologyj.com/content/4/1/73
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rogen) to drive A12L expression under its native pro-
moter, which contains 233 upstream nucleotides (p233-
A12L). To place A12L ORF in both pRB21 and TOPO vec-
tor, two different sets of primers were designed; pA12L-
forward: 5'-CACTCCATGGATGGCGG ATAAAAAAAATT-
TAGCC and pA12L-reverse: 5'-CAGGATCCTTAATACAT-
TCCCATATCCA GACAAC; p233-forward: 5'-
ATGGCGGATAAAAAAAATTTAGCC and A12L-reverse: 5'-
TTA ATACATTCCCATATCCAGACAAAATTCG. In order to
construct A12L with abrogated cleavage at an N-terminal
AG/A site (AG/A), the AG/A sites were altered into ID/I by
site-directed mutagenesis kit (Stratagene) with a specific
primer, which has the changed sequences at the residues
55–57 (underlined), 5'-
CTTAATTCTCAAACAGATGTGACTATCGACATCTGTGA-
TACAAAATCAAAGAGTTCA-3'. The AG/A site-mutated
A12L was inserted in pRB21 vector.
For transfection of the plasmids into T-REx 293 cells,
infection media of D-MEM medium was placed in new
eppendorf tubes and mixed with 2 to 10 µg of DNA and
30 µl of the transfection reagent, DMRIE-C (Invitrogen).
After vortexing the mixture, it was placed at room temper-
ature for 20 min. and loaded on 6-well plates of ~ 60%
confluent T-REx 293 cells. The cells were incubated at
37°C for 5–6 hours and infected by vvtetOA12L at an MOI
of 1 PFU/cell for 24 hours. Virus titers were determined as
described earlier.
Electron microscopy
T-REx 293 cells were infected at an MOI of 1 PFU/cell with
vvtetOA12L and harvested at 24 hpi by centrifugation
(270 × g) at 4°C. The cell extracts were resuspended with
1X PBS, followed by incubation with fixative buffer (2%
glutaraldehyde, 1.25% paraformaldehyde in 0.1 M
cacodylate buffer [pH7.3]) for 2 hours at room tempera-
ture. Postfixation, ultrathin section, and staining were per-
formed as described [22].
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